Clovis Oncology announces 2016 operating results
Clovis Oncology reported a net loss for the 2016 fourth quarter of $70.7 million versus a net loss of $119.5 million in the same 2015 period. Clovis had $266.2 million in cash, cash equivalents and available-for-sale securities as of Dec. 31, 2016. February 22, 2017